New drug combination shows promise for African sleeping sicknessNovember 07, 2007A small clinical trial in Uganda, conducted within a long-established Médecins Sans Frontières (MSF) treatment program for African sleeping sickness, has found that a new combination treatment using the drugs nifurtimox and eflornithine holds promise and deserves further evaluation. The parasitic disease African sleeping sickness (human African trypanosomiasis, or HAT) threatens millions across remote and conflict-affected regions of sub-Saharan Africa, and causes about 15 000 reported cases every year. Without treatment, HAT progresses from stage 1, infection of the blood and lymph, to stage 2, invasion of the central nervous system, and then to death. There are few drugs available for treating stage 2. The historical mainstay, melarsoprol, is highly toxic and is ineffective in some areas due to parasite resistance. Eflornithine is the only viable alternative, already established as safe and efficacious, but it is difficult to administer-it is given intravenously and requires 24 hour nursing care, placing an additional workload on the already fragile health systems in HAT-endemic countries. The new trial, by Gerardo Priotto (Epicentre, Paris, France) and colleagues at MSF and Epicentre, reports on a series of 48 patients treated with a novel combination of nifurtimox (a drug registered for Chagas disease) and eflornithine. Seventeen patients were recruited as part of a terminated randomized trial (previously published in PLoS Clinical Trials, at http://dx.doi.org/10.1371/journal.pctr.0010039), and 31 in a subsequent case series study. Despite the low sample size, the findings were promising: no cases of treatment failure, no treatment terminations, and no HAT- or treatment-related deaths. "Nifurtimox plus eflornithine may be the best treatment hope for stage 2 HAT patients in the next decade, while new drugs are developed," say the authors. "A larger, multi-centric trial of the combination is ongoing." Public Library of Science |
|||||||||||||||||||||
| Related Sleeping Sickness Current Events and Sleeping Sickness News Articles Possible help in fight against muscle-wasting disease A compound already used to treat pneumonia could become a new therapy for an inherited muscular wasting disease, according to researchers at the University of Oregon and the University of Rochester School of Medicine and Dentistry in New York. How much is the world spending on neglected disease research and development? The first comprehensive survey of global spending on neglected disease R&D, published in this week's PLoS Medicine, finds that just over $US 2.5 billion was invested into R&D of new products in 2007, with three diseases-HIV/AIDS, TB, and malaria-receiving nearly 80% of the total. Scans show immune cells intercepting parasites Researchers may have identified one of the body's earliest responses to a group of parasites that causes illness in developing nations. DNA chunks, chimps and humans Researchers have carried out the largest study of differences between human and chimpanzee genomes, identifying regions that have been duplicated or lost during evolution of the two lineages. Death by hyperdisease It took less than a decade for native rats to become extinct on the Indian Ocean's previously uninhabited Christmas Island once Eurasian black rats jumped ship onto the island at the turn of the 20th century. 'Deadly dozen' reports diseases worsened by climate change Health experts from the Wildlife Conservation Society today released a report that lists 12 pathogens that could spread into new regions as a result of climate change, with potential impacts to both human and wildlife health and global economies. New UNC laboratory to help track and control tropical diseases The University of North Carolina at Chapel Hill School of Public Health has established a new Gillings Innovation Lab to track and map tropical infectious diseases such as malaria, using state-of-the-art molecular and demographic methods. Sleeping sickness finding could lead to earlier diagnosis Sleeping sickness creates a metabolic 'fingerprint' in the blood and urine, which could enable a new test to be developed to diagnose the disease, according to new research published today in the journal Proceedings of the National Academy of Sciences. Study finds multiple neglected tropical diseases effectively treated with drugs The neglected tropical diseases are a group of 13 infectious diseases, including elephantiasis, hookworm, African sleeping sickness and trachoma, which affect more than 1 billion people worldwide, most of whom live in extreme poverty. UGA researchers discover how human body fights off African parasite Trypanosoma are a nasty class of single-celled parasites that cause serious, even fatal, diseases in human and animals. More Sleeping Sickness Current Events and Sleeping Sickness News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||